Back to Programme

Technologies Helping in the Fight against Neurodegenerative Diseases

February, 13
10:00–11:30
Neurotechnologies in Healthcare
World Trade Center Moscow, entrance No. 4, 1st floor, conference hall No. 2. Gazprombank
Just as life expectancies continue to grow in developed countries, so does the proliferation of age-specific diseases, including neurodegenerative ones, such as Alzheimer’s, Parkinson’s, and motor neurons, among others. That said, contemporary life in cities can be fast-paced and accompanied with high stress levels, which leads to a phenomenon when neurodegenerative pathologies begin to affect ever younger populations. At present, scientists from around the world are trying to understand how these diseases emerge and progress in order to develop a way to prevent them. However, even now some have been successful at creating therapies that can hinder the progression of such diseases, and can even eliminate certain prominent symptoms. Individual therapies allow patients to choose an optimal algorithm for treatment, including pharmacological methods based on genomic analysis, neuro-surgical, and innovative neuro-rehabilitative technologies. What advanced technologies for the diagnosis and treatment of neurodegenerative diseases exist? What is the quickest and most economical method for determining whether there is a heredity risk for developing Alzheimer’s? What is the current status of and what does the future hold for treating neurodegenerative diseases? What personalized programmes for rehabilitating patients with neurodegenerative diseases have proved to be most effective and successful?
Moderator:
Darya Kryuchko
Head of the Department of Translational Medicine and Innovative Technologies, Federal Medical and Biological Agency (FMBA of Russia)
Panellists:
Anna Bogolepova
Head of the Department of Cognitive Disorders, Federal Centre of Brain Research and Neurotechnologies of the Federal Medical-Biological Agency of the Russian Federation; Professor, Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University of the Russian Ministry of Health
Ivan Ivanov
granary manager
Sergey Illarioshkin
Deputy Director for Research, Director of the Brain Institute, The Research Center of Neurology
Denis Kuleshov
Innovator and Chief Executive Officer, Sensor-Tech
Vladimir Mitkevich
Deputy Director, V.A. Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences
Boris Polyaev
Head of the Department of Medical Rehabilitation of Patients with Disorders of the Central Nervous System No. 2; Federal Center for Brain and Neurotechnology of the Federal Medical-Biological Agency of the Russian Federation
Nikolay Shamalov
Director of the Institute of Cerebrovascular Pathology and Stroke, Federal Center for Brain and Neurotechnology of the Federal Medical-Biological Agency of the Russian Federation; Сhief Supernumerary Specialist Neurologist of the Ministry of Health of the Russian Federation
Front row participant:
Evgeny Nikolaev
Professor, Skoltech Center for Molecular and Cellular Biology